To Analyze the Differences in Plasma Lipid Composition Among Healthy, Prediabetic and Type 2 Diabetic Populations Based on Lipidomics

Authors

  • Yanli Gu
  • Xinyue Liu
  • Zhe Gao

DOI:

https://doi.org/10.54097/bkbc3512

Keywords:

Prediabetic, Type 2 Diabetic, Lipidomics

Abstract

Pre-diabetes and type 2 diabetes mellitus (T2DM) are important stages of metabolic disorders, in which abnormal lipid metabolism plays a key role. In recent years, the development of lipidomics technology has provided a new perspective to reveal the differences in plasma lipid composition between pre-diabetes and T2DM patients. This paper discusses the changes of plasma lipid profile in patients with prediabetes and T2DM based on lipidomics, and looks forward to future research directions, in order to provide new ideas for early intervention and treatment of prediabetes patients.

Downloads

Download data is not yet available.

References

[1] Association Diabetes Association.2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021.Diabetes Care,2021,44: S15-S33.

[2] Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 2017; 317: 2515–2523.

[3] Yang WY, Lu JM, Weng JP.Prevalenece of diabetes among men and women in China[J].N Engl J Med,2010, 362:1090-1102.

[4] Wang L, Gao P,Zhang M,et al.Prevalence and ethnic pattern of diabetes and prediabetes in China in,2013[J]. JAMA,2017, 317 (24):2515-2523.

[5] Wu Q, Guan Y, Xu CZ,,et al. Relationship of serum uric acid with prediabetes and newly detected type 2 diabetes mellitus[J]. Chinese Journal of Epidemiology,2022,43 (10):1603.

[6] Liu Mingzhu. Retinal changes in prediabetes and preclinical diabetic retinopathy [J]. Journal of ophthalmology, 2023, 38 (6): 454-460. The DOI: 10.12419/2303310004.

[7] Butler AE, English E, Kilpatrick ES,et al.Diagnosing type 2 diabetes using hemoglobin A1C:A systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications.Acta Diabetol,2021,58:279-300.

[8] SHEN X L. Effect of community comprehensive intervention on disease progression of pre-diabetes patients[J]. Chinese General Practice, 2012, 15(32): 3769-3770. DOI:10.3969/j. issn. 1007-9572. 2012. 32. 065.

[9] Luo chao, Chen Jie, Mao lei, Xi feng, Shen Ke, Guo Yanying. Correlation between obesity-related indicators and T2DM in patients with prediabetes [J]. International journal of laboratory medicine, 2024, (7): 813-817. The DOI: 10.3969 / j.i SSN. 1673-4130. 2024. 07. 011.

[10] Sas KM, Karnovsky A, Michailidis G, Pennathur S. Metabolomics and diabetes: analytical and computational approaches. Diabetes (2015) 64(3):718–32. doi: 10.2337/db14-0509.

[11] Morze J, Wittenbecher C, Schwingshackl L, Danielewicz A, Rynkiewicz A, Hu FB, et al. Metabolomics and type 2 diabetes risk: An updated systematic review and meta-analysis of prospective cohort studies. Diabetes Care (2022) 45(4):1013–24. doi: 10.2337/dc21-1705.

[12] Xuan Q, Hu C, Zhang Y, Wang Q, Zhao X, et al. Serum lipidomics profiles reveal potential lipid markers for prediabetes and type 2 diabetes in patients from multiple communities. Front. Endocrinol. 2022; 13:814912. doi: 10. 3389/ fendo.2022.814912.

[13] Barranco-Altirriba M., Alonso N., Weber R.J.M., Lloyd G.R., Hernandez M., Yanes O., Capellades J., Jankevics A., Winder C., Falguera M., et al. Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus. Cardiovasc. Diabetol. 2024; 23:109. doi: 10.1186/s12933-024-02202-5.

[14] Yang J., Wang M., Yang D., Yan H., Wang Z., Yan D., Guo N. Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients. Front. Endocrinol. 2023;13 doi: 10.3389/fendo.2022.1065665.

[15] Zhong H, Fang C, Fan Y, Lu Y, Wen B, Ren H et al. Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals. Gigascience 2017;6. 10.1093/gigascience/gix036.

[16] Shao F, Hu X, Li J, Bai B, Tian L. Lipidomics analysis of impaired glucose tolerance and type 2 diabetes mellitus in overweight or obese elderly adults. Endocr Connect. 2023; 12(12): e230212. Published 2023 Nov 15. doi:10. 1530/ EC-23-0212.

[17] Tommi, Suvitaival, Isabel,et al. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men[J].Metabolism: Clinical and Experimental, 2018.

Downloads

Published

26-02-2025

Issue

Vol. 9 No. 2 (2025)

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.